Академический Документы
Профессиональный Документы
Культура Документы
,
P
i
, and ammoni a) and/or the depl eti on of stored energy
substrates [ATP, phosphocreati ne (PCr), and gl ycogen]
(13). Housh et al . (8, 9) have reported that mani pul a-
ti on of bl ood aci d-base bal ance wi th ammoni a chl ori de
and sodi um bi carbonate, as wel l as gl ycogen depl eti on
and supercompensati on, di d not affect the onset of
NMF as measured by the PWC
FT
test. However, McCart-
ney et al . (12) have suggested that al terati ons i n the
bl ood aci d-base state have l i ttl e i nuence on muscl e
pH. I n addi ti on, there i s evi dence to suggest that
skel etal muscl e PCr may serve as a temporal energy
buffer as wel l as a modul ator of gl ycol ysi s and, there-
fore, may i nuence NMF (22). The effect of PCr mani pu-
l ati on on EMG fati gue curves, however, i s unknown.
Therefore, the purpose of the present study was to
determi ne the effect of Cr l oadi ng on the onset of NMF,
as measured by the PWC
FT
test i n women athl etes.
METHODS
Subjects. Fi fteen femal e members of the uni versi ty crew
team [age 19.0 2.0 (SD) yr] vol unteered as subjects for thi s
i nvesti gati on. Al l procedures were approved by the I nsti tu-
ti onal Revi ew Board before the i ni ti ati on of the study, and
each subject was advi sed of any possi bl e ri sks before provi d-
i ng i nformed consent.
Supplementation protocol. None of the subjects had i n-
gested Cr, or any other di etary suppl ements, for a mi ni mum
of 12 wk before the i ni ti ati on of the study. Duri ng the course
of the study, the subjects were asked to mai ntai n thei r
current di etary patterns and abstai n from other nutri ti onal
suppl ements, nonprescri pti on drugs, and caffei ne. After pre-
testi ng, the subjects were randoml y assi gned to one of two
treatment condi ti ons usi ng a doubl e-bl i nd desi gn: 1) 20 g of
avored dextrose powder as a pl acebo (Pl , n 8); or 2) 5.0 g of
Cr monohydrate pl us 20 g of dextrose i n a avored powder
bl end (Cr, n 7) (Creati ne Edge Effervescent, Fortress
Systems, Omaha, NE). The powders, i denti cal i n taste and
appearance, were di ssol ved i n 16 oz of water and i ngested
four ti mes per day for 5 consecuti ve days before posttesti ng.
The costs of publ i cati on of thi s arti cl e were defrayed i n part by the
payment of page charges. The arti cl e must therefore be hereby
marked advertisement i n accordance wi th 18 U.S.C. Secti on 1734
sol el y to i ndi cate thi s fact.
J . Appl. Physiol.
88: 109112, 2000.
8750-7587/00 $5.00 Copyri ght
2000 the Ameri can Physi ol ogi cal Soci ety 109 http://www.jap.org
Electrodeplacement and EMG instrumentation. A bi pol ar
(2.54-cm center-to-center) surface el ectrode (Qui nton Qui ck
prep si l ver-si l ver chl ori de) arrangement was pl aced on the
ri ght thi gh over the l ateral porti on of the vastus l ateral i s
(VL), mi dway between the greater trochanter and the l ateral
condyl e of the femur. The reference el ectrode was pl aced over
the i l i ac crest. I nterel ectrode i mpedance was kept bel ow
2,000 by careful abrasi on of the ski n. The EMG si gnal was
preampl i ed (gai n: 1,000) by usi ng a di fferenti al ampl i er
(EMG 100, Bi opac System, Santa Barbara, CA). The EMG
si gnal was sampl ed at 1,000 poi nts/s and l tered at 10500
Hz. The root mean square EMG ampl i tude val ues were
cal cul ated for the 10-s ti me frame for each sampl e taken
(MP100, Bi opac Systems).
Determination of PWC
FT
. The PWC
FT
val ues were deter-
mi ned from the VL muscl e by usi ng the protocol of deVri es et
al . (3). Fi gure 1 i l l ustrates how the PWC
FT
was determi ned
usi ng the data from subject 7 i n the Cr group (Tabl e 1). The
subjects began pedal i ng (wi th toe cl i ps) at 60 W (70 rpm) on a
cal i brated, el ectroni cal l y braked cycl e ergometer (Corval 400,
Qui nton I nstruments, Seattl e, WA). The power output was
then i ncreased by 30 W every 2 mi n unti l the subject coul d no
l onger mai ntai n 70 rpm. Duri ng each 2-mi n i nterval , si x 10-s
EMG sampl es were recorded from the VL. The PWC
FT
was
determi ned by averagi ng the hi ghest power output that
resul ted i n a nonsi gni cant (P 0.05; si ngl e-tai l ed t-test)
sl ope val ue for the EMG ampl i tude vs. ti me rel ati onshi p, wi th
the l owest power output that resul ted i n a si gni cant (P
0.05) sl ope val ue (Fi g. 1).
Rel i abi l i ty of the PWC
FT
was determi ned by usi ng a
subsampl e of subjects (n 11) measured 7 days apart. The
test-retest i ntracl ass correl ati on coeffi ci ent (R) was 0.94
(SE 6 W), whi ch i s si mi l ar to val ues reported by deVri es et
al . (2, 3) i n ol der (R 0.976) and younger mal e subjects (R
0.947). I n addi ti on, the test-retest mean di fference for the
PWC
FT
val ues 0.5 W was not stati sti cal l y si gni cant (t 0.09;
P 0.05).
Statistical analysis. Changes i n body wei ght (BW) as a
resul t of suppl ementati on were anal yzed by usi ng a 2 2
[treatment (Pl , Cr) ti me (pretest, postest)] mi xed factori al
ANOVA. Di fferences i n the mean posttest PWC
FT
val ue were
determi ned by usi ng anal ysi s of covari ance, wi th pretest
PWC
FT
servi ng as the covari ate. Data were consi dered si gni -
cantl y di fferent when the probabi l i ty was P 0.05.
RESULTS
The descri pti ve characteri sti cs of the subjects, as
wel l as the changes i n BW and PWC
FT
for the two
groups, are shown i n Tabl e 1. There were no si gni cant
changes i n BW from pretesti ng to posttesti ng for ei ther
group. However, the adjusted mean posttest PWC
FT
val ue for the Pl group (mean 155 W) was si gni cantl y
l ess than that of the Cr group (mean 186 W).
Fi g. 1. I l l ustrati on of method used for determi ni ng physi cal worki ng
capaci ty at fati gue threshol d (PWC
FT
) for subject 7i n creati ne group.
EMG, el ectromyographi c vol tages; NS, not si gni cant; uVrms, root
mean square EMG ampl i tude.
Tabl e 1. Characteristics of thesubjects (n15)
Subject Age, yr Hei ght, cm BW-Pre, kg BW-Post, kg PWC
FT
-Pre, W PWC
FT
-Post, W
Placebogroup
1 18 163 75.5 75.0 165 135
2 19 165 51.4 51.8 135 135
3 19 167 56.4 56.0 135 135
4 20 167 59.0 59.6 165 165
5 17 170 80.5 81.8 135 165
6 19 164 70.5 69.9 165 165
7 21 160 60.5 59.0 105 105
8 19 163 56.0 56.0 165 165
Mean SD 19.01.2 164.93.1 63.710.4 63.610.6 146.322.3 146.322.3
Creatinegroup
1 17 172 74.3 76.4 165 225
2 21 154 66.7 68.2 165 195
3 20 163 67.3 65.0 195 225
4 22 159 64.0 64.5 165 195
5 18 166 78.9 78.7 225 225
6 18 167 62.7 63.4 165 165
7 20 178 65.5 64.7 105 135
Mean SD 19.41.8 165.68.0 68.55.9 68.76.3 169.336.4 195*34.6
PWC
FT
, physi cal worki ng capaci ty at fati gue threshol d; BW, body wei ght; Pre, before treatment; Post, after treatment. *Mean PWC
FT
-Post
val ues si gni cantl y di fferent from mean PWC
FT
-Pre val ues (P0.05).
110 CREATI NE LOADI NG ON NEUROMUSCULAR FATI GUE
DISCUSSION
Recent i nvesti gati ons (6, 10) usi ng mal e subjects
have shown that Cr l oadi ng (20 g/day) for 5 days
si gni cantl y el evated whol e muscl e Cr stores by an
average of 20%, wi th as much as 20%stored i n the form
of PCr. Vandenberghe et al . (20) demonstrated a 6%
i ncrease i n muscl e PCr concentrati on i n col l ege-age
women (1922 yr ol d) after 4 days of Cr l oadi ng. The
femal e subjects i n the present study (Tabl e 1) were
si mi l ar i n age (1821 yr ol d) and cl osel y fol l owed the Cr
l oadi ng regi men used i n the study by Vandenberghe et
al . (20) (5 g, four ti mes per day for 5 days). Therefore,
al though muscl e PCr l evel s were not di rectl y measured
i n the present study, the resul ts of previ ous i nvesti ga-
ti ons (6, 10, 20) suggest that i t i s l i kel y that the Cr
l oadi ng resul ted i n an i ncrease i n muscl e PCr concentra-
ti on.
Several studi es that have exami ned the ergogeni c
effect of Cr l oadi ng on performance by usi ng supramaxi -
mal workl oads on a cycl e ergometer have reported
si gni cant i ncreases i n total work duri ng both si ngl e
and mul ti pl e bouts of exerci se (1, 11, 17, 22). Recentl y,
Jacobs et al . (11) and Prevost et al . (17) demonstrated
si gni cant i ncreases i n ti me to exhausti on (8.5 and
24%, respecti vel y) duri ng cycl e ergometry at 125 and
150% maxi mal oxygen consumpti on rate after Cr l oad-
i ng i n physi cal l y acti ve men and women. Prevost et al .
hypothesi zed that Cr l oadi ng i ncreased exerci se capac-
i ty and di mi ni shed the exerci se-i nduced ri se i n pl asma
l actate l evel s by del ayi ng anaerobi c gl ycol ysi s. I n con-
trast, Febbrai o et al . (5) demonstrated no si gni cant
di fferences i n ti me to exhausti on and i ntramuscul ar
l actate l evel s duri ng cycl e ergometry at 115120% of
maxi mal oxygen consumpti on rate after Cr l oadi ng i n
untrai ned men.
Fewer studi es have been conducted to determi ne the
effects of Cr l oadi ng on submaxi mal exerci se perfor-
mance (16, 18). Nel son et al . (16) recentl y reported that
Cr l oadi ng i n mal e and femal e athl etes (age range
2127 yr) resul ted i n a 12% i ncrease i n the venti l atory
threshol d as wel l as a decrease i n bl ood l actate and
ammoni a concentrati ons duri ng i ncremental cycl e er-
gometry. I n contrast, Stroud et al . (18) reported that Cr
l oadi ng had no effect on respi ratory gas exchange or
bl ood l actate accumul ati on duri ng i ncremental tread-
mi l l exerci se i n physi cal l y acti ve men. Di screpanci es i n
the l i terature regardi ng the effects of Cr l oadi ng on
performance may be attri buted to the hi ghl y vari abl e
i nteri ndi vi dual response i n muscl e Cr retenti on as a
resul t of Cr l oadi ng (1, 6). Recentl y, Casey et al . (1)
demonstrated a posi ti ve rel ati onshi p (r 0.71, P
0.05) between anaerobi c exerci se performance duri ng
cycl e ergometry and the magni tude of muscl e Cr reten-
ti on from Cr l oadi ng, and they concl uded that the
i mprovement i n anaerobi c performance was cri ti cal l y
dependent on the magni tude of muscl e Cr retenti on
fol l owi ng l oadi ng.
McCl aren et al . (13) have suggested that a decrease
i n muscl e pH, as a resul t of the accumul ati on of H
or
i ntra- and extracel l ul ar ammoni a, may be responsi bl e
for fati gue-i nduced i ncreases i n MU recrui tment and
the correspondi ng i ncrease i n EMG ampl i tude. I n
agreement, Tayl or et al . (19) al so found that, for
i ncr emental cycl e er gometr y, the accumul ati on of
pl asma l actate and ammoni a was associ ated wi th an
i ncrease i n EMG ampl i tude measured from the rectus
femori s muscl e. Therefore, there i s evi dence to suggest
that a rel i ance on anaerobi c gl ycol ysi s l eads to an
i ncrease i n EMG ampl i tude from the worki ng muscl es
as a resul t of changes i n muscl e and bl ood l actate l evel s
and the correspondi ng decrease i n pH.
I n the present study, Cr l oadi ng resul ted i n a del ay i n
the onset of NMF (as measured by the PWC
FT
test),
whi ch may have been due to the effect of el evated
muscl e PCr on the transi ti on from aerobi c to anaerobi c
metabol i sm. Prevost et al . (17) and Vol ek and Kraemer
(22) have hypothesi zed that i ncreasi ng muscl e PCr
content by Cr l oadi ng may decrease the rel i ance on
anaerobi c gl ycol ysi s, reduce i ntramuscul ar l actate accu-
mul ati on, and, therefore, del ay the onset of fati gue.
Thus the resul ts of the present study suggest that
duri ng i ncremental cycl e ergometry Cr l oadi ng may
del ay the onset of NMF and the fati gue-i nduced i n-
crease i n EMG at submaxi mal power outputs by reduc-
i ng the rel i ance on anaerobi c gl ycol ysi s and attenuat-
i ng the accumul ati on of l actate and ammoni a i n the
worki ng muscl es and bl ood.
I n summary, Cr l oadi ng resul ted i n a si gni cantl y
hi gher PWC
FT
val ue (186 W) compared wi th a Pl
(155 W), i ndi cati ng that Cr l oadi ng may del ay the onset
of NMF duri ng i ncremental cycl e ergometry i n femal e
athl etes. The del ay i n NMF may have been due to
augmented PCr l evel s i n the muscl e, whi ch may have
resul ted i n a greater capaci ty to del ay anaerobi c gl ycol y-
si s (16, 17, 22). Future studi es that woul d di rectl y
measure muscl e PCr, l actate, and ammoni um l evel s are
warranted to val i date these resul ts.
We thank Fortress I nternati onal (Omaha, NE) for fundi ng thi s
study.
Address for repri nt requests and other correspondence: J. R. Stout,
Crei ghton Uni v., Exerci se Sci ence Dept., 2500 Cal i forni a Pl ., Omaha,
NE 68178 (E-mai l : jrstout@crei ghton.edu).
Recei ved 14 May 1999; accepted i n nal form 31 August 1999.
REFERENCES
1. Casey, A., D. Constantin-Teodosiu, S. Howell, E. Hultman,
and P. L. Greenhaff. Creati ne i ngesti on favorabl y affects
performance and muscl e metabol i sm duri ng maxi mal exerci se i n
humans. Am. J . Physiol. Endocrinol. Metab. 271: E31E37,
1996.
2. DeVries, H. A., G. R. Brodowicz, L. D. Robertson, M. D.
Svoboda, J . S. Schendel, A. M. Tichy, and M. W. Tichy.
Esti mati ng physi cal worki ng capaci ty and trai ni ng changes i n
the el derl y at the fati gue threshol d (PWC
FT
). Ergonomics 32:
967977, 1989.
3. DeVries, H.A., T. J . Housh, G. O. J ohnson, S.A. Evans, G. D.
Tharp, D. J . Housh, and R. A. Hughes. Factors affecti ng the
esti mati on of physi cal worki ng capaci ty at the fati gue threshol d.
Ergonomics33: 2533, 1990.
4. DeVries, H. A., M. W. Tichy, T. J . Housh, K. D. Symth, A. M.
Tichy, and D. J . Housh. A method for esti mati ng physi cal
worki ng capaci ty at the fati gue threshol d (PWC
FT
). Ergonomics
30: 11951204, 1987.
5. Febbraio, M., T. Flanagan, R. Snow, S. Zhao, andM. Carey.
Effect of creati ne suppl ementati on on i ntramuscul ar TCr, metabo-
111 CREATI NE LOADI NG ON NEUROMUSCULAR FATI GUE
l i sm and performance duri ng i ntermi ttent, supramaxi mal exer-
ci se i n humans. Acta Physiol. Scand. 155: 387395, 1995.
6. Harris, R. C., K. Soderlund, and E. Hultman. El evati on of
creati ne i n resti ng and exerci sed muscl e of normal subjects by
creati ne suppl ementati on. Clin. Sci. (Colch.) 83: 367374, 1992.
7. Hela, J . N., C. Y. Guezennec, and F. Goubel. The aerobi c-
anaerobi c transi ti on: re-exami nati on of the threshol d concept
i ncl udi ng and el ectromyographi c approach. Eur. J . Appl. Physiol.
56: 643649, 1987.
8. Housh, T. J ., H. A. deVries, G. O. J ohnson, S. A. Evans, and
S. McDowell. The effect of ammoni um chl ori de and sodi um
bi carbonate i ngesti on on the physi cal worki ng capaci ty at the
fati gue threshol d. Eur. J . Appl. Physiol. 62: 189192, 1991.
9. Housh, T. J ., H.A. deVries, G. O. J ohnson, S.A. Evans, G. D.
Tharp, D. J . Housh, and R. J . Hughes. The effect of gl ycogen
depl eti on and supercompensati on on the physi cal worki ng capac-
i ty at the fati gue threshol d. Eur. J . Appl. Physiol. 60: 391394,
1990.
10. Hultman, E., K. Soderlund, J . A. Timmons, G. Cereblad,
and P. L. Greenhaff. Muscl e creati ne l oadi ng i n men. J . Appl.
Physiol. 81: 232237, 1996.
11. J acobs, I., S. Bleue, and J . Goodman. Creati ne i ngesti on
i ncreases anaerobi c capaci ty and maxi mum accumul ated oxygen
deci t. Can. J . Appl. Physiol. 22: 231243, 1997.
12. McCartney, N., G. J . F. Heignehauser, and N. L. J ones.
Effects of pH on maxi mal power output and fati gue duri ng
short-term dynami c exerci se. J . Appl. Physiol. 55: 225229,
1983.
13. McClaren, D. P., H. Gibson, M. Parry-Billings, and R. H. T.
Edwards. A revi ew of metabol i c and physi ol ogi cal factors i n
fati gue. Exerc. Sport Sci. Rev. 17: 2968, 1989.
14. Matsumoto, T., K. Ito, and T. Moritani. The rel ati onshi p
between anaerobi c threshol d and el ectromyographi c fati gue
threshol d i n col l ege women. Eur. J . Appl. Physiol. 63: 15, 1990.
15. Moritani, T., T. Takaishi, and T. Matsumoto. Determi nati on
of maxi mal power output at neuromuscul ar fati gue threshol d. J .
Appl. Physiol. 74: 17291734, 1993.
16. Nelson, A., R. Day, E. Glickman-Weiss, M. Hegstad, and B.
Sampson. Creati ne suppl ementati on rai ses anaerobi c threshol d
(Abstract). FASEB J . 11: A589, 1997.
17. Prevost, M. C., A. G. Nelson, and G. S. Morris. Creati ne
suppl ementati on enhances i nter mi ttent wor k per for mance.
Res. Q. Exerc. Sport 68: 233240, 1997.
18. Stroud, M., D. Holliman, D. Bell, A. Green, I. Macdonald,
and P. Greenhaff. Effect of oral creati ne suppl ementati on on
respi ratory gas exchange and bl ood l actate accumul ati on duri ng
steady-state i ncremental treadmi l l exerci se and recovery i n man.
Clin. Sci. (Colch.) 87: 707710, 1994.
19. Taylor, A. D., R. Bronks, and A. L. Bryant. The rel ati onshi p
between el ectromyography and work i ntensi ty revi si ted: a bri ef
revi ew wi th references to l acti caci dosi s and hyperammoni a.
Electromyogr. Clin. Neurophysiol. 37: 387398, 1997.
20. Vanderberghe,K.,M.Goris,P.VanHecke,M.VanLeeputte,
L. Vangerven, and P. Hespel. Long-term creati ne i ntake i s
beneci al to muscl e perfomance duri ng resi stance trai ni ng. J .
Appl. Physiol. 83: 20552063, 1997.
21. Viitasalo, J . T., P. Luhtanen, P. Rahkila, and H. Rusko.
El ectromyographi c acti vi ty rel ated to aerobi c and anaerobi c
threshol d i n ergometer bi cycl i ng. Acta Physiol. Scand. 124:
287293, 1985.
22. Volek, J . S., andW. J . Kraemer. Creati ne suppl ementati on: i ts
effect on human muscul ar performance and body composi ti on. J .
Strength Cond. Res. 10: 200210, 1996.
112 CREATI NE LOADI NG ON NEUROMUSCULAR FATI GUE